Detalhe da pesquisa
1.
Integrated Pharmacokinetic/Pharmacodynamic Analysis for Determining the Minimal Anticipated Biological Effect Level of a Novel Anti-CD28 Receptor Antagonist BMS-931699.
J Pharmacol Exp Ther
; 355(3): 506-15, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26442523